Recognizing bisphosphonate-induced ear osteonecrosis in primary care: a case report.
Alasdair W MayerDare OladokunDipan MistryPublished in: Family practice (2024)
MRECO, a rare complication of anti-resorptive therapy, is anticipated to rise with increasing antiresorptive medication use in the ageing population. Unexplained ear symptoms in those with a history of current or prior anti-resorptive therapy should raise clinical concern, prompting evaluation for exposed bone in the EAC. Raising awareness of MRECO among primary care providers is crucial for early diagnosis and timely management.